| Integrity Diabetic Shoes Inc | |
|
117 N Garfield Ave, Sand Springs, OK 74063-7214 | |
| (918) 924-2557 | |
| Not Available |
| Full Name | Integrity Diabetic Shoes Inc |
|---|---|
| Type | Facility |
| Speciality | Durable Medical Equipment & Medical Supplies |
| Location | 117 N Garfield Ave, Sand Springs, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184235921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Secondary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Integrity Diabetic Shoes Inc 117 N Garfield Ave, Sand Springs, OK 74063-7214 Ph: (918) 924-2557 | Integrity Diabetic Shoes Inc 117 N Garfield Ave, Sand Springs, OK 74063-7214 Ph: (918) 924-2557 |
News Archive
A pilot study among young children with Type 1 diabetes found that a University of Virginia-developed artificial pancreas helped study participants better control their condition.
Results from the largest study of artificial intelligence use in the English Diabetic Eye Screening Programme (DESP), have shown that the technology can accurately detect serious eye disease among those with diabetes (retinopathy) and could halve the human workload associated with screening for diabetic eye disease, saving millions of pounds annually.
Numerous processes in our body fluctuate in a regular pattern during the day. These circadian (or daily) variations can be driven by local oscillators present within our cells or by systemic signals controlled by the master pacemaker, located in the brain. Ueli Schibler, professor at the University of Geneva (UNIGE), Switzerland, unveils a molecular mechanism by which body temperature rhythms influence the expression of 'clock genes' and synchronize local oscillators.
Myriad Genetics, Inc. today announced new clinical studies on its myChoice HRD companion diagnostic test at the 2015 American Society of Clinical Oncology annual meeting being held in Chicago, Ill.
› Verified 2 days ago